A recent study reveals a significant rise in stimulant prescriptions for adults in Ontario, particularly among women, following the onset of the COVID-19 pandemic. The findings highlight a growing trend in the diagnosis of attention deficit hyperactivity disorder (ADHD) among adults, raising concerns about both access to treatment and the potential for overdiagnosis.
Dramatic Rise in Prescriptions
According to research published by the Canadian Medical Association Journal (CMAJ), the number of adults in Ontario who received new prescriptions for stimulant medications, such as Vyvanse and Concerta, surged to over 220,000 in the four years following March 2020. This marks a steep increase from approximately 107,000 adults in the preceding four years. Initial declines in prescriptions were observed immediately after the pandemic began, when healthcare services were largely restricted to COVID-19 cases. However, as telehealth options expanded, prescriptions quickly rebounded.
Notably, women accounted for 59 per cent of new stimulant users during this period, a considerable rise from 48 per cent before the pandemic. Dr. Mina Tadrous, a pharmacist and drug policy researcher at the University of Toronto, noted the unusual speed of this increase. “We don’t often see this rapid of a growth in a drug class, especially one that has been around for so long,” she remarked, urging for further investigation into this trend.
Rise in Adult ADHD Awareness
The CMAJ study aligns with previous research that has documented a similar surge in adult ADHD diagnoses, particularly among women. A study published in JAMA Network Open corroborated these findings, noting that healthcare professionals in Canada, the United States, and Europe are witnessing a heightened awareness of ADHD symptoms in adults.
Dr. Daniel Myran, a research chair in family and community medicine at North York General Hospital, expressed intrigue at the increasing number of young adults seeking stimulant prescriptions after receiving ADHD diagnoses from for-profit virtual care clinics. The CMAJ study indicated that 29 per cent of new patients obtained their prescriptions through virtual consultations post-March 2020, compared to almost none beforehand, highlighting a marked shift towards remote healthcare.
“This can be done very quickly from the comfort of your home,” Dr. Myran explained. While this accessibility can facilitate legitimate diagnoses, it also raises the risk of overdiagnosis, which is concerning due to the potential side effects of stimulant medications, including cardiovascular issues and, in rare cases, manic episodes.
Factors Behind the Increase
Several theories have emerged regarding the uptick in adult ADHD diagnoses. Some researchers suggest that increased screen time during the pandemic may have exacerbated attention-related symptoms, leading to genuine diagnoses. Others point to the influence of social media, particularly platforms like TikTok, where discussions about ADHD have proliferated, potentially encouraging self-diagnosis among viewers.
Emma Climie, a registered psychologist and associate professor at the University of Calgary, emphasised that many women are now being diagnosed with ADHD in their 30s and 40s. She and her colleague Brandy Callahan are conducting a long-term study focused on adult women with ADHD. Dr. Climie noted that some women only become aware of their symptoms after their children receive ADHD diagnoses. For others, the coping mechanisms that worked during their youth may falter under the pressures of modern life, leading to feelings of burnout and inadequacy.
“They’re really struggling with, ‘Why does it look like everybody else has everything together? And I’m not able to do this,’” Dr. Climie shared. This emotional burden underscores the complexities surrounding the recognition and treatment of ADHD in women.
Why it Matters
The surge in stimulant prescriptions for adults highlights a critical shift in how ADHD is understood and diagnosed, particularly among women. It raises important questions about the adequacy of mental health services, the role of telemedicine, and the potential consequences of overdiagnosis. As awareness of ADHD continues to evolve, it is essential to ensure that those seeking help receive accurate diagnoses and appropriate treatment, while also safeguarding against the risks associated with stimulant medications. This phenomenon not only reflects the changing landscape of mental health care but also underscores the ongoing need for cultural sensitivity and understanding in addressing the unique challenges faced by women with ADHD.
